REQUEST A DEMO
Total
USD $0.00
Search more companies

Nashmir Capsule Sdn Bhd (Malaysia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Nashmir Capsule Sdn Bhd Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

To carry on business dealing in all type of empty capsules, purchase and sell, lease and rent property;restaurant;manufacture of pharmaceutical and medical goods in health and cosmetic products.

Headquarters
No.1639 , Jalan Perusahaan Bukit Tengah, Jalan Pelangi
Perai; Penang; Postal Code: 13600

Contact Details: Purchase the Nashmir Capsule Sdn Bhd report to view the information.

Basic Information
Outstanding Shares:
Purchase the Nashmir Capsule Sdn Bhd report to view the information.
Registered Capital:
Purchase the Nashmir Capsule Sdn Bhd report to view the information.
Financial Auditors:
Purchase the Nashmir Capsule Sdn Bhd report to view the information.
Incorporation Date:
February 28, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Nashmir Capsule Sdn Bhd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
15.47%
Total operating revenue
15.47%
Operating profit (EBIT)
-21.63%
EBITDA
3.6%
Net Profit (Loss) for the Period
-72.22%
Total assets
59.61%
Total equity
7.41%
Operating Profit Margin (ROS)
-4.58%
Net Profit Margin
-10.82%
Return on Equity (ROE)
-19.78%
Debt to Equity Ratio
22.91%
Quick Ratio
-1.49%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?